EARNEST PARTNERS LLC Myriad Genetics, Inc. Transaction History

EARNEST PARTNERS LLC portfolio value:

$125.36M
portfolio value

EARNEST PARTNERS LLC quarter portfolio value change:

+5.01%
quarter

Myriad Genetics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +1.68% 108.26K shares 7.94M $19.08 6.57M
Q2 2022 share Increase +2.95% 185.07K shares -40.76M $18.17 6.46M
Q1 2022 share Decrease -0.62% -39.30K shares -16.15M $25.2 6.27M
Q4 2021 share Increase +1.03% 64.55K shares -27.53M $27.64 6.31M
Q3 2021 share Increase +0.94% 58.33K shares 12.47M $32.29 6.25M
Q2 2021 share Decrease -13.80% -991.87K shares -29.39M $30.58 6.19M
Q1 2021 share Increase +6.74% 453.92K shares 85.68M $30.45 7.18M
Q4 2020 share Increase +36.11% 1.78M shares 68.62M $19.78 6.73M
Q3 2020 share Increase +3.88% 184.52K shares 10.5M $13.04 4.94M
Q2 2020 share Increase +14.44% 600.79K shares -5.54M $11.34 4.76M
Q1 2020 share Increase +15.60% 561.53K shares -38.46M $14.31 4.16M
Q4 2019 share Increase +6.21% 210.50K shares 988K $27.23 3.59M
Q3 2019 share Increase 0.00% 3.38M shares 97.00M $28.63 3.38M